Compare EWTX & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EWTX | IPAR |
|---|---|---|
| Founded | 2017 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.1B |
| IPO Year | 2021 | 1995 |
| Metric | EWTX | IPAR |
|---|---|---|
| Price | $27.96 | $95.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $36.00 | ★ $125.50 |
| AVG Volume (30 Days) | ★ 703.0K | 240.9K |
| Earning Date | 05-27-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.34% |
| EPS Growth | N/A | ★ 7.79 |
| EPS | N/A | ★ 4.36 |
| Revenue | N/A | ★ $1,317,700,000.00 |
| Revenue This Year | N/A | $4.47 |
| Revenue Next Year | N/A | $8.23 |
| P/E Ratio | ★ N/A | $21.93 |
| Revenue Growth | N/A | ★ 21.26 |
| 52 Week Low | $10.60 | $77.21 |
| 52 Week High | $31.82 | $142.50 |
| Indicator | EWTX | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 41.32 |
| Support Level | $27.00 | $92.30 |
| Resistance Level | $31.12 | $102.38 |
| Average True Range (ATR) | 1.36 | 3.49 |
| MACD | -0.40 | -1.32 |
| Stochastic Oscillator | 18.74 | 26.22 |
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.